Vanderbilt University: Study Shows Liraglutide Results in Increased Insulin Sensitivity Independent of Weight Loss
January 05, 2024
January 05, 2024
NASHVILLE, Tennessee, Jan. 5 (TNSres) -- Vanderbilt University Medical Center issued the following news:
By Jill Clendening
A new study published in the journal Diabetes demonstrates that a glucagon-like peptide-1 receptor (GLP-1R) agonist, a member of a class of medication used to treat Type 2 diabetes and obesity, can lead to a rapid improvement in insulin sensitivity.
Insulin sensitivity is how responsive cells are to insulin, an essential hormone that c . . .
By Jill Clendening
A new study published in the journal Diabetes demonstrates that a glucagon-like peptide-1 receptor (GLP-1R) agonist, a member of a class of medication used to treat Type 2 diabetes and obesity, can lead to a rapid improvement in insulin sensitivity.
Insulin sensitivity is how responsive cells are to insulin, an essential hormone that c . . .